Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Equal Voice in Virtual Meetings – Perks of Virtual Medical Education

August 1, 2024 | CME, Continuing medical education, Impetus Digital, Online education, Perks of virtual, Perks of virtual education, Virtual medical education, Virtual training, digital education, med ed, medical education, virtual education 

In virtual meetings, every participant has the chance to be heard. Our new video from the “Perks of Virtual Medical Education” series explores how features like chat and Q&A ensure that all voices contribute to the conversation, enhancing inclusivity and balance.

Explore how virtual meetings ensure that everyone has an opportunity to contribute in our fourth video from the “Perks of Virtual Medical Education” series. See why virtual environments are more inclusive for all participants.

4. In Virtual Meetings, Everyone Gets a Say Virtual meetings democratize participation, offering every participant an equal opportunity to contribute. Unlike in-person discussions, which can often be dominated by a few vocal individuals, virtual meetings, especially well-executed ones, level the playing field. Tools such as chat functions and Q&A features in web meeting platforms allow participants to share their thoughts without interrupting the ongoing discussion. Furthermore, asynchronous formats like online forums or app-based activities enable participants to take their time in formulating thoughtful responses, reducing impulsive reactions and promoting more considered contributions. This inclusive approach ensures that all voices are heard, making discussions richer and more balanced.

For more insights into how virtual meetings can enhance your educational and collaborative efforts, visit our blog: https://www.impetusdigital.com/2020/09/17/top-10-reasons-why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/

Enhance your virtual engagements with Impetus Digital:

Stay connected for more empowering strategies:

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...